Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. 1996

W E Thierfelder, and J M van Deursen, and K Yamamoto, and R A Tripp, and S R Sarawar, and R T Carson, and M Y Sangster, and D A Vignali, and P C Doherty, and G C Grosveld, and J N Ihle
Department of Biochemistry, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Signal transducers and activators of transcription (STATs) are activated by tyrosine phosphorylation in response to cytokines and mediate many of their functional responses. Stat4 was initially cloned as a result of its homology with Stat1 (refs 4, 5) and is widely expressed, although it is only tyrosine-phosphorylated after stimulation of T cells with interleukin (IL)-12 (refs 6,7). IL-12 is required for the T-cell-independent induction of the cytokine interferon (IFN)-gamma, a key step in the initial suppression of bacterial and parasitic infections. IL-12 is also important for the development of a Th1 response, which is critical for effective host defence against intracellular pathogens. To determine the function of Stat4 and its role in IL-12 signalling, we have produced mice that lack Stat4 by gene targeting. The mice were viable and fertile, with no detectable defects in haematopoiesis. However, all IL-12 functions tested were disrupted, including the induction of IFN-gamma, mitogenesis, enhancement of natural killer cytolytic function and Th1 differentiation.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic

Related Publications

W E Thierfelder, and J M van Deursen, and K Yamamoto, and R A Tripp, and S R Sarawar, and R T Carson, and M Y Sangster, and D A Vignali, and P C Doherty, and G C Grosveld, and J N Ihle
May 2000, Blood,
W E Thierfelder, and J M van Deursen, and K Yamamoto, and R A Tripp, and S R Sarawar, and R T Carson, and M Y Sangster, and D A Vignali, and P C Doherty, and G C Grosveld, and J N Ihle
July 2011, Journal of leukocyte biology,
W E Thierfelder, and J M van Deursen, and K Yamamoto, and R A Tripp, and S R Sarawar, and R T Carson, and M Y Sangster, and D A Vignali, and P C Doherty, and G C Grosveld, and J N Ihle
September 2002, The European respiratory journal,
W E Thierfelder, and J M van Deursen, and K Yamamoto, and R A Tripp, and S R Sarawar, and R T Carson, and M Y Sangster, and D A Vignali, and P C Doherty, and G C Grosveld, and J N Ihle
January 2010, Hepatology (Baltimore, Md.),
W E Thierfelder, and J M van Deursen, and K Yamamoto, and R A Tripp, and S R Sarawar, and R T Carson, and M Y Sangster, and D A Vignali, and P C Doherty, and G C Grosveld, and J N Ihle
July 1995, Journal of immunology (Baltimore, Md. : 1950),
W E Thierfelder, and J M van Deursen, and K Yamamoto, and R A Tripp, and S R Sarawar, and R T Carson, and M Y Sangster, and D A Vignali, and P C Doherty, and G C Grosveld, and J N Ihle
January 2010, Immunology,
W E Thierfelder, and J M van Deursen, and K Yamamoto, and R A Tripp, and S R Sarawar, and R T Carson, and M Y Sangster, and D A Vignali, and P C Doherty, and G C Grosveld, and J N Ihle
May 2012, Journal of the Formosan Medical Association = Taiwan yi zhi,
W E Thierfelder, and J M van Deursen, and K Yamamoto, and R A Tripp, and S R Sarawar, and R T Carson, and M Y Sangster, and D A Vignali, and P C Doherty, and G C Grosveld, and J N Ihle
August 2010, Experimental & molecular medicine,
W E Thierfelder, and J M van Deursen, and K Yamamoto, and R A Tripp, and S R Sarawar, and R T Carson, and M Y Sangster, and D A Vignali, and P C Doherty, and G C Grosveld, and J N Ihle
February 2001, Proceedings of the National Academy of Sciences of the United States of America,
W E Thierfelder, and J M van Deursen, and K Yamamoto, and R A Tripp, and S R Sarawar, and R T Carson, and M Y Sangster, and D A Vignali, and P C Doherty, and G C Grosveld, and J N Ihle
April 2003, Infection and immunity,
Copied contents to your clipboard!